Wolfe Research initiated coverage on Incyte with a new price target

10/1/24 7:36:44 AM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Wolfe Research initiated coverage of Incyte with a rating of Outperform and set a new price target of $84.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$INCY

Date	Price Target	Rating	Analyst
6/16/2025	$107.00	Hold → Buy	Stifel
3/18/2025		Buy → Neutral	Guggenheim
3/18/2025		Outperform → Mkt Perform	William Blair
12/17/2024	$77.00	Neutral	UBS
10/29/2024	$68.00 → $90.00	Neutral → Buy	BofA Securities
10/1/2024	$84.00	Outperform	Wolfe Research
9/18/2024	$83.00 → $74.00	Buy → Hold	Truist
7/2/2024	$52.00 → $48.00	Market Perform → Underperform	BMO Capital Markets